235 related articles for article (PubMed ID: 27421669)
1. An evolutionary, structural and functional overview of the mammalian TEAD1 and TEAD2 transcription factors.
Landin-Malt A; Benhaddou A; Zider A; Flagiello D
Gene; 2016 Oct; 591(1):292-303. PubMed ID: 27421669
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of TEAD transcription factors and its coactivators in cancers.
Pobbati AV; Hong W
Cancer Biol Ther; 2013 May; 14(5):390-8. PubMed ID: 23380592
[TBL] [Abstract][Full Text] [Related]
3. Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors.
Lu W; Fan M; Ji W; Tse J; You I; Ficarro SB; Tavares I; Che J; Kim AY; Zhu X; Boghossian A; Rees MG; Ronan MM; Roth JA; Hinshaw SM; Nabet B; Corsello SM; Kwiatkowski N; Marto JA; Zhang T; Gray NS
J Med Chem; 2023 Apr; 66(7):4617-4632. PubMed ID: 36946421
[TBL] [Abstract][Full Text] [Related]
4. Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy.
Bokhovchuk F; Mesrouze Y; Izaac A; Meyerhofer M; Zimmermann C; Fontana P; Schmelzle T; Erdmann D; Furet P; Kallen J; Chène P
FEBS J; 2019 Jun; 286(12):2381-2398. PubMed ID: 30903741
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional analysis of the YAP-binding domain of human TEAD2.
Tian W; Yu J; Tomchick DR; Pan D; Luo X
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7293-8. PubMed ID: 20368466
[TBL] [Abstract][Full Text] [Related]
6. Targeting Transcriptional Enhanced Associate Domains (TEADs).
Gibault F; Sturbaut M; Bailly F; Melnyk P; Cotelle P
J Med Chem; 2018 Jun; 61(12):5057-5072. PubMed ID: 29251924
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy.
Pobbati AV; Han X; Hung AW; Weiguang S; Huda N; Chen GY; Kang C; Chia CS; Luo X; Hong W; Poulsen A
Structure; 2015 Nov; 23(11):2076-86. PubMed ID: 26592798
[TBL] [Abstract][Full Text] [Related]
8. Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival.
Sawada A; Kiyonari H; Ukita K; Nishioka N; Imuta Y; Sasaki H
Mol Cell Biol; 2008 May; 28(10):3177-89. PubMed ID: 18332127
[TBL] [Abstract][Full Text] [Related]
9. TEAD family transcription factors in development and disease.
Currey L; Thor S; Piper M
Development; 2021 Jun; 148(12):. PubMed ID: 34128986
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes.
Pobbati AV; Chan SW; Lee I; Song H; Hong W
Structure; 2012 Jul; 20(7):1135-40. PubMed ID: 22632831
[TBL] [Abstract][Full Text] [Related]
11. VGLL4 and MENIN function as TEAD1 corepressors to block pancreatic β cell proliferation.
Li F; Liu R; Negi V; Yang P; Lee J; Jagannathan R; Moulik M; Yechoor VK
Cell Rep; 2023 Jan; 42(1):111904. PubMed ID: 36662616
[TBL] [Abstract][Full Text] [Related]
12. A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors.
Mesrouze Y; Aguilar G; Bokhovchuk F; Martin T; Delaunay C; Villard F; Meyerhofer M; Zimmermann C; Fontana P; Wille R; Vorherr T; Erdmann D; Furet P; Scheufler C; Schmelzle T; Affolter M; Chène P
Sci Rep; 2020 Oct; 10(1):17442. PubMed ID: 33060790
[TBL] [Abstract][Full Text] [Related]
13. The surprising features of the TEAD4-Vgll1 protein-protein interaction.
Mesrouze Y; Hau JC; Erdmann D; Zimmermann C; Fontana P; Schmelzle T; Chène P
Chembiochem; 2014 Mar; 15(4):537-42. PubMed ID: 24504694
[TBL] [Abstract][Full Text] [Related]
14. Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs.
Liberelle M; Toulotte F; Renault N; Gelin M; Allemand F; Melnyk P; Guichou JF; Cotelle P
J Med Chem; 2022 Apr; 65(8):5926-5940. PubMed ID: 35389210
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule Cyanamide Pan-TEAD·YAP1 Covalent Antagonists.
Bum-Erdene K; Yeh IJ; Gonzalez-Gutierrez G; Ghozayel MK; Pollok K; Meroueh SO
J Med Chem; 2023 Jan; 66(1):266-284. PubMed ID: 36562717
[TBL] [Abstract][Full Text] [Related]
16. Discovering inhibitors of TEAD palmitate binding pocket through virtual screening and molecular dynamics simulation.
Li Y; Li Y; Ning C; Yue J; Zhang C; He X; Wang Y; Liu Z
Comput Biol Chem; 2022 Jun; 98():107648. PubMed ID: 35288361
[TBL] [Abstract][Full Text] [Related]
17. TEAD transcription factors are required for normal primary myoblast differentiation in vitro and muscle regeneration in vivo.
Joshi S; Davidson G; Le Gras S; Watanabe S; Braun T; Mengus G; Davidson I
PLoS Genet; 2017 Feb; 13(2):e1006600. PubMed ID: 28178271
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the Hippo Pathway Transcription Factor TEAD.
Lin KC; Park HW; Guan KL
Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
[TBL] [Abstract][Full Text] [Related]
19. DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.
Shi Z; He F; Chen M; Hua L; Wang W; Jiao S; Zhou Z
Oncogene; 2017 Jul; 36(30):4362-4369. PubMed ID: 28368398
[TBL] [Abstract][Full Text] [Related]
20. Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain.
Anbanandam A; Albarado DC; Nguyen CT; Halder G; Gao X; Veeraraghavan S
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17225-30. PubMed ID: 17085591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
